Corporate GovernanceApr 28, 2026, 04:08 PM
LSTA Amends 10-K Part III; Updates Board & Executive Officer Details
AI Summary
LISATA THERAPEUTICS, INC. (LSTA) filed an Amendment No. 1 to its Form 10-K, restating Part III items related to Directors, Executive Officers, and Corporate Governance. The amendment provides updated biographical information for the six-member classified Board of Directors and four executive officers. It also details the company's corporate governance structure, including independent directors, board leadership, risk oversight, insider trading policy, and the composition and duties of its Audit, Compensation, Nominating and Governance, and Science and Technology Committees.
Key Highlights
- Amendment No. 1 restates 5 items (10-14) of Form 10-K Part III.
- Board of Directors comprises 6 members across 3 classes.
- Executive officer team consists of 4 individuals.
- Audit Committee has 3 independent directors, met 5 times.
- Compensation Committee has 3 independent directors, met 6 times.
- Nominating and Governance Committee has 3 independent directors, met 4 times.
- Science and Technology Committee has 3 members, met 4 times.
- Dr. Gregory B. Brown (72) serves as Chairman of the Board.
Price Impact
More from LSTA